Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review

A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests reveale...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 59; no. 1; pp. 113 - 118
Main Authors Sumi, Masahiko, Kitahara, Mari, Shishido, Tsutomu, Kazumoto, Hiroko, Uematsu, Nozomu, Kirihara, Takehiko, Sato, Keijiro, Ueki, Toshimitsu, Hiroshima, Yuki, Shimizu, Kunihiko, Kobayashi, Hikaru
Format Journal Article
LanguageEnglish
Published Japan The Japanese Society of Internal Medicine 01.01.2020
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.
Bibliography:ObjectType-Case Study-3
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Review-1
ObjectType-Feature-5
ObjectType-Report-2
ObjectType-Article-4
Correspondence to Dr. Masahiko Sumi, sumin@nagano-med.jrc.or.jp
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.3322-19